Global Retirement Partners LLC Sells 322 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Global Retirement Partners LLC decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.9% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 10,756 shares of the medical equipment provider’s stock after selling 322 shares during the period. Global Retirement Partners LLC’s holdings in Intuitive Surgical were worth $5,284,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Nomura Holdings Inc. acquired a new stake in Intuitive Surgical in the 4th quarter valued at $3,049,000. NBC Securities Inc. raised its holdings in Intuitive Surgical by 34.4% during the first quarter. NBC Securities Inc. now owns 121 shares of the medical equipment provider’s stock worth $48,000 after acquiring an additional 31 shares in the last quarter. Ferguson Wellman Capital Management Inc. boosted its position in Intuitive Surgical by 9.1% during the first quarter. Ferguson Wellman Capital Management Inc. now owns 850 shares of the medical equipment provider’s stock valued at $339,000 after purchasing an additional 71 shares during the last quarter. Massmutual Trust Co. FSB ADV increased its position in shares of Intuitive Surgical by 7.8% during the 1st quarter. Massmutual Trust Co. FSB ADV now owns 930 shares of the medical equipment provider’s stock worth $371,000 after purchasing an additional 67 shares during the last quarter. Finally, Montecito Bank & Trust acquired a new position in Intuitive Surgical during the first quarter worth approximately $324,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the stock in a transaction that occurred on Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total value of $641,382.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the business’s stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total transaction of $641,382.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,655,048.26. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 53,120 shares of company stock worth $25,528,753. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ ISRG traded down $1.57 during mid-day trading on Thursday, reaching $475.02. 547,281 shares of the stock were exchanged, compared to its average volume of 1,458,718. The stock has a 50 day simple moving average of $482.49 and a 200-day simple moving average of $436.65. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $496.48. The stock has a market cap of $168.49 billion, a P/E ratio of 86.03, a P/E/G ratio of 5.40 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.24. The company had revenue of $2.01 billion during the quarter, compared to analyst estimates of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. Intuitive Surgical’s revenue for the quarter was up 14.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.18 EPS. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on ISRG shares. JPMorgan Chase & Co. increased their price target on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Truist Financial lifted their price objective on Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a report on Monday. Royal Bank of Canada increased their target price on Intuitive Surgical from $515.00 to $525.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and boosted their price target for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Finally, Stifel Nicolaus increased their price objective on shares of Intuitive Surgical from $430.00 to $475.00 and gave the stock a “buy” rating in a research note on Friday, July 19th. Six research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $474.16.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.